Arixtra: Uses, Dosage, Demographic, Side Effects, Interactions, and Generic Options Arixtra is a medication that is used to prevent blood clots from forming in patients who have undergone certain surgeries or have certain medical conditions. It is administered subcutaneously, and its active ingredient is fondaparinux. This drug belongs to a class of medicines known as antithrombotics, which are intended to prevent thrombosis by inhibiting clotting factors. Uses of Arixtra Arixtra is used to treat or prevent blood clots that can occur in the legs (deep venous thrombosis) or lungs (pulmonary embolism) after certain surgeries like hip or knee replacement surgery. It is also used to treat unstable angina and non-ST segment elevation myocardial infarction. Dosage and Administration of Arixtra Arixtra is administered through a subcutaneous injection and is available in different doses. The dosage that is prescribed to the patient depends on factors like weight, age, gender, the severity of the condition, and the type of surgery or medical condition. The recommended dose varies from 2.5mg to 7.5mg, depending on the patient's medical history. Demographics Served by Arixtra Arixtra is targeted towards patients who are at risk of developing blood clots due to the following: - Hip or knee replacement surgery - Unstable angina - Non-ST segment elevation myocardial infarction Arixtra is not suitable for patients with a history of stroke, thrombocytopenia, or bleeding disorders. Side Effects of Arixtra Common side effects of Arixtra include: - Bruising, bleeding - Injection site pain - Anemia - Abnormal liver function Serious side effects: - Allergic reactions like rash, hives, difficulty breathing, and swelling in the face, lips, tongue, or throat - Spinal or epidural hematomas - Prolonged bleeding - Blood clots in other parts of the body Interactions with Other Drugs Arixtra may interact with other medications. It is important for patients to inform their doctor if they are taking other anticoagulants, such as warfarin or heparin. It may also interact with drugs that have an antiplatelet effect such as clopidogrel or prasugrel. Generic Options for Arixtra Fondaparinux sodium is the generic version of Arixtra. Like the branded version, it is a subcutaneously administered injection that helps prevent deep vein thrombosis and pulmonary embolism. Conclusion Arixtra is a medication that is used to prevent blood clots from forming in patients who have undergone certain surgeries or have certain medical conditions. The medication is given in different doses depending on the patient's medical history. Although there are some common side effects, patients should also be aware of the possible serious side effects that may occur. Patients taking Arixtra should speak to their doctor to understand the drug's potential drug interactions. Fondaparinux sodium is the generic version of Arixtra, and it is just as effective as the branded version.